Editorial: Decoding checkpoint inhibitor-induced endocrinopathies

被引：1
作者：
Burnett, Deborah L. [1 ,2 ]
Barnet, Megan B. [1 ,2 ,3 ]
Samaras, Katherine [2 ,4 ,5 ]
机构：
[1] Garvan Inst Med Res, Immunol Div, Darlinghurst, NSW, Australia
[2] Univ New South Wales UNSW, Fac Med & Hlth, Sch Clin Med, St Vincents Healthcare Clin Campus, Sydney, NSW, Australia
[3] St Vincents Hosp, Dept Med Oncol, Darlinghurst, NSW, Australia
[4] St Vincents Hosp, Dept Endocrinol, Darlinghurst, NSW, Australia
[5] Garvan Inst Med Res, Clin Obes Nutr & Adipose Biol Lab, Clin Sci Pillar, Darlinghurst, NSW, Australia
来源：
FRONTIERS IN ENDOCRINOLOGY | 2022年 / 13卷
基金：
英国医学研究理事会;
关键词：
immune checkpoint (ICP); cancer immunotherapies; irAE; autoimmune disease; endocrinopathies; ADVERSE EVENTS; METASTATIC MELANOMA; THERAPY; CTLA-4; HYPOPHYSITIS; ASSOCIATION; IPILIMUMAB; SURVIVAL; GENETICS;
D O I：
10.3389/fendo.2022.987648
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 26 条
[1]   Case Report: Ipilimumab-Induced Panhypophysitis: An Infrequent Occurrence and Literature Review [J].
Barnabei, Agnese ;
Carpano, Silvia ;
Chiefari, Alfonsina ;
Bianchini, Marta ;
Lauretta, Rosa ;
Mormando, Marilda ;
Puliani, Guilia ;
Paoletti, Giancarlo ;
Appetecchia, Marialuisa ;
Torino, Francesco .
FRONTIERS IN ONCOLOGY, 2020, 10
[2]   Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints [J].
Chang, Lee-Shing ;
Barroso-Sousa, Romualdo ;
Tolaney, Sara M. ;
Hodi, F. Stephen ;
Kaiser, Ursula B. ;
Min, Le .
ENDOCRINE REVIEWS, 2019, 40 (01) :17-65
[3]   Genetics of Type 1A Diabetes [J].
Concannon, Patrick ;
Rich, Stephen S. ;
Nepom, Gerald T. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (16) :1646-1654
[4]   Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients [J].
De Velasco, Guillermo ;
Je, Youjin ;
Bosse, Dominick ;
Awad, Mark M. ;
Ott, Patrick A. ;
Moreira, Raphael B. ;
Schutz, Fabio ;
Bellmunt, Joaquim ;
Sonpavde, Guru P. ;
Hodi, F. Stephen ;
Choueiri, Toni K. .
CANCER IMMUNOLOGY RESEARCH, 2017, 5 (04) :312-318
[5]   Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes [J].
Dillard, Troy ;
Yedinak, Chris G. ;
Alumkal, Joshi ;
Fleseriu, Maria .
PITUITARY, 2010, 13 (01) :29-38
[6]   HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: Analysis of the Type 1 Diabetes Genetics Consortium families [J].
Erlich, Henry ;
Valdes, Ana Maria ;
Noble, Janelle ;
Carlson, Joyce A. ;
Varney, Mike ;
Concannon, Pat ;
Mychaleckyj, Josyf C. ;
Todd, John A. ;
Bonella, Persia ;
Fear, Anna Lisa ;
Lavant, Eva ;
Louey, Anthony ;
Moonsamy, Priscilla .
DIABETES, 2008, 57 (04) :1084-1092
[7]   Autoimmune diabetes induced by PD-1 inhibitor-retrospective analysis and pathogenesis: a case report and literature review [J].
Gauci, Marie-Lea ;
Laly, Pauline ;
Vidal-Trecan, Tiphaine ;
Baroudjian, Barouyr ;
Gottlieb, Jeremy ;
Madjlessi-Ezra, Nika ;
Da Meda, Laetitia ;
Madelaine-Chambrin, Isabelle ;
Bagot, Martine ;
Basset-Seguin, Nicole ;
Pages, Cecile ;
Mourah, Samia ;
Boudou, Philippe ;
Lebbe, Celeste ;
Gautier, Jean-Francois .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (11) :1399-1410
[8]   Original Research Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy [J].
Ghisoni, E. ;
Wicky, A. ;
Bouchaab, H. ;
Imbimbo, M. ;
Delyon, J. ;
Moura, B. Gautron ;
Gerard, C. L. ;
Latifyan, S. ;
Ozdemir, B. C. ;
Caikovski, M. ;
Pradervand, S. ;
Tavazzi, E. ;
Gatta, R. ;
Marandino, L. ;
Valabrega, G. ;
Aglietta, M. ;
Obeid, M. ;
Homicsko, K. ;
Alfonso, N. N. Mederos ;
Zimmermann, S. ;
Coukos, G. ;
Peters, S. ;
Cuendet, M. A. ;
Di Maio, M. ;
Michielin, O. .
EUROPEAN JOURNAL OF CANCER, 2021, 149 :153-164
[9]   Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer [J].
Godwin, James Luke ;
Jaggi, Shuchie ;
Sirisena, Imali ;
Sharda, Pankaj ;
Rao, Ajay D. ;
Mehra, Ranee ;
Veloski, Colleen .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[10]   Combination immune checkpoint inhibitor therapy nivolumab and ipilimumab associated with multiple endocrinopathies [J].
Gunawan, Florence ;
George, Elizabeth ;
Roberts, Adam .
ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2018,
123